Pattern Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for cancer breast in Iran 2009 to 2019: an observational study based on the global burden of diseases

Author:

Shoorabeh Fazlollah Fathollahi1,Khazaei Zaher2,Pordanjani Sajjad Rahimi3,Abbasi Mahshid4,goodarzi Elham1

Affiliation:

1. Lorestan University of Medical Sciences

2. Shahid Sadoughi University of Medical Sciences

3. Semnan University of Medical Sciences

4. Shahid Rahimi Hospital Lorestan University of Medical Sciences

Abstract

Abstract Breast cancer is the first type of malignancy and the leading cause of cancer-related deaths in women worldwide. The purpose of this study is to investigate the epidemiology of breast cancer in Iran and its relationship with the human development index. The present study is a descriptive analytical study. Data related to the incidence, mortality, years of life with disability (YLDs), YLLs and DALYs of breast cancer in Iran were extracted from the World Burden of Disease 2019 website. Correlation tests are used to check the relationship between these indicators and the human development index. The highest incidence rate of breast cancer in 2019 is related to the provinces of Gilan (29 per 100,000) and Tehran (28.55 per 100,000) and the highest rate of death from breast cancer is related to the provinces of Gilan (10.71 per 100,000). and Semnan (9.97 in 100,000). The results showed that there is a positive and significant correlation between DALY (r = 0.626, P < 0.0001), YLL (r = 0.611, P < 0.0001) and YLD (r = 0.773, P < 0.0001) breast cancer with HDI index. There is a positive and significant correlation between the incidence (r = 0.794, P < 0.0001) and mortality (r = 0.503, P = 0.003) of breast cancer with the HDI index. Considering that the incidence and mortality rate of breast cancer in the country is increasing, in the fight against breast cancer, an appropriate strategy should be adopted with universal health coverage and, finally, approaches Screening and treatment of breast cancer can reduce the burden caused by this cancer in the country.

Publisher

Research Square Platform LLC

Reference47 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA: a cancer journal for clinicians,2021

2. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study;Heer E;The Lancet Global Health,2020

3. Global incidence and mortality of liver cancers and its relationship with the human development index (HDI): an ecology study in 2018;Goodarzi E;World Cancer Res J,2019

4. The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases;Anderson BO;The Lancet Oncology,2021

5. Breast cancer epidemiology and risk factors;Rojas K;Clinical obstetrics and gynecology,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3